Century Therapeutics (IPSC) EBT Margin (2022 - 2025)
Century Therapeutics (IPSC) posted quarterly EBT Margin of 70.13% for Q1 2025, up 335212.0% year-over-year from N/an in Q1 2024, and up 108.53% quarter-over-quarter from 821.88% in Q4 2024.
Powered by 
Analysis
Century Therapeutics (IPSC) EBT Margin (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported EBT Margin for 4 consecutive years, with 70.13% the latest figure, recorded in Q1 2025.
- In Q1 2025, EBT Margin rose 335212.0% year-over-year to 70.13%; the TTM figure through Dec 2025 stood at 0.05% (up 189348.0% YoY), while the FY2025 annual figure was 0.04%, up 189374.0% from the prior year.
- EBT Margin climbed to 70.13% in Q1 2025 per IPSC's latest filing, from 821.88% in the prior quarter.
- Across five years, EBT Margin topped out at 70.13% in Q1 2025 and bottomed at 32667.68% in Q2 2023.
- Historically, EBT Margin has averaged 7414.95% across 4 years, with a median of 3544.14% in 2022.
- Annual changes were most pronounced in 2023 — EBT Margin slumped 3044920 bps — and 2024, when it jumped 2862293 bps.
- Century Therapeutics' EBT Margin stood at 6074.86% in 2022, then slumped by 147 bps to 15025.0% in 2023, then surged by 95 bps to 821.88% in 2024, then surged by 109 bps to 70.13% in 2025.
- Business Quant data shows IPSC's EBT Margin at 70.13% in Q1 2025, 821.88% in Q4 2024, and 3948.67% in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 70.13% |
| Dec 31, 2024 | -822.00% |
| Sep 30, 2024 | -3,948.67% |
| Jun 30, 2024 | -4,044.75% |
| Mar 31, 2024 | -3,281.99% |
| Dec 31, 2023 | -15,025.00% |
| Sep 30, 2023 | -21,708.11% |
| Jun 30, 2023 | -32,667.68% |
| Mar 31, 2023 | -1,747.44% |
| Dec 31, 2022 | -6,074.86% |
| Sep 30, 2022 | -1,381.47% |
| Jun 30, 2022 | -2,218.48% |
| Mar 31, 2022 | -3,544.14% |